Skip to content

XOMA Corporation XOMA Debt Repayments

Debt Repayments at other companies

Innoviva, Inc. logo
Innoviva, Inc.INVA
$0
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0-100%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$500M
KKR & Co. logo
KKR & Co.KKR
$3.26B-37.0%
Apollo Global Management logo
Apollo Global ManagementAPO
$1.42B+73.5%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's debt repayments?
XOMA Corporation (XOMA) reported debt repayments of $6.39M in Q1 2026.
How has XOMA Corporation's debt repayments changed year-over-year?
XOMA Corporation's debt repayments increased by 26.2% year-over-year, from $5.07M to $6.39M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.